Hypercatabolism and Anti-catabolic Therapies in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome.
Hypercatabolism and Anti-catabolic Therapies in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome.
复制标题
DOI:
10.3389/fnut.2022.941097
复制
发表时间:
2022
影响因子:
5
通讯作者:
Zhong, Jing
中科院分区:
文献类型:
--
作者:
Zhang, Jinlin;Luo, Wenchen;Miao, Changhong;Zhong, Jing
关键词:
Owing to the development of intensive care units, many patients survive their initial insults but progress to chronic critical illness (CCI). Patients with CCI are characterized by prolonged hospitalization, poor outcomes, and significant long-term mortality. Some of these patients get into a state of persistent low-grade inflammation, suppressed immunity, and ongoing catabolism, which was defined as persistent inflammation, immunosuppression, and catabolism syndrome (PICS) in 2012. Over the past few years, some progress has been made in the treatment of PICS. However, most of the existing studies are about the role of persistent inflammation and suppressed immunity in PICS. As one of the hallmarks of PICS, hypercatabolism has received little research attention. In this review, we explore the potential pathophysiological changes and molecular mechanisms of hypercatabolism and its role in PICS. In addition, we summarize current therapies for improving the hypercatabolic status and recommendations for patients with PICS.
登录
查看更多内容
影响因子:
4.4
作者:
Barker G;Winer JR;Guirgis FW;Reddy S
通讯作者:
Reddy S
影响因子:
7.7
作者:
den Besten, Gijs;Bleeker, Aycha;Bakker, Barbara M.
通讯作者:
Bakker, Barbara M.
影响因子:
4.1
作者:
Chao T;Porter C;Herndon DN;Siopi A;Ideker H;Mlcak RP;Sidossis LS;Suman OE
通讯作者:
Suman OE
影响因子:
3.9
作者:
Barker G;Leeuwenburgh C;Brusko T;Moldawer L;Reddy ST;Guirgis FW
通讯作者:
Guirgis FW
影响因子:
19
作者:
Bar-Peled, Liron;Sabatini, David M.
通讯作者:
Sabatini, David M.